3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
16
Peritoneal Neoplasms
14
Colorectal Neoplasms
11
Uterine Cervical Neoplasms
9
Stomach Neoplasms
9
Endometrial Neoplasms
8
Neoplasm Metastasis
7
Urinary Bladder Neoplasms
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Lung Neoplasms
4
Fallopian Tube Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Mesothelioma
3
HIV Infections
3
Cholangiocarcinoma
3
Carcinoma, Renal Cell
3
Carcinoma, Ovarian Epithelial
3
Acquired Immunodeficiency Syndrome
3
Uterine Neoplasms
2
Uterine Cervical Dysplasia
2
Squamous Intraepithelial Lesions
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Interventions
human papillomavirus vaccine, L1 type 16, 18
16
Papillomavirus Vaccines
12
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Vaccines
5
Human Papillomavirus DNA Tests
5
Colposcopy
5
Specimen Handling
4
Blood Specimen Collection
4
Watchful Waiting
3
Vaginal Smears
3
Patient Navigation
3
Engerix-B
3
Educational Status
3
fludarabine phosphate
2
fludarabine
2
artesunic acid
2
artemisinin
2
aldesleukin
2
Vaccines, Synthetic
2
Standard of Care
2
Practice Guidelines as Topic
2
Polymerase Chain Reaction
2
Mass Screening
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
GX-188 vaccine
2
Early Intervention, Educational
2
Data Collection
2
Cyclophosphamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Fluorouracil
×
Gynecologic
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts